Table: begin end state 1 39 cytoplasmic 40 57 transmembrane 58 78 non-cytoplasmic 79 97 transmembrane 98 107 cytoplasmic 108 134 transmembrane 135 190 non-cytoplasmic 191 214 transmembrane 215 255 cytoplasmic 256 275 transmembrane 276 294 non-cytoplasmic 295 318 transmembrane 319 329 cytoplasmic 330 347 transmembrane 348 352 non-cytoplasmic 353 377 transmembrane 378 388 cytoplasmic 389 412 transmembrane 413 418 non-cytoplasmic 419 439 transmembrane 440 450 cytoplasmic
Input: >AO353_06195 FitnessBrowser__pseudo3_N2E3:AO353_06195 MIPSQSSHTESARMASGLGVATGGIGDKIRGAMAVGKTRWGMLALVFFATTLNYIDRAAL GVMQPILAKEMSWTAMDYANINFWFQVGYAVGFVLQGRLIDRIGVKRVFFCAVLLWSLAT GAHGLATSALGFMVCRFILGLTEAANYPACVKTTRLWFPAGERAVATGIFNAGTNVGAMF TPMLLPLILHVWGWQAAFLCMSALGGIWLVFWGLKYFNPEDHPSVKQSELDYIQNEAEPE QARVPFSRILRMRGTWAFALAYSMTAPVFWFYLYWLPPFLNQQYNLGINVTQMGIPLIII YMTADFGSVGGGILSSFLIGRGVNPIKARLMSMLLFACCIIGVIMAAGSSNLWVAVFAIS LAIGAHQAWTANIWSLVMDYTPKHMMSTVFGFGGMCAAIGGMFMTQLVGHILTITNNNYT VLFTMIPAMYFIALIWLYFMAPRKIPNLED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server